News for Q BioMed Inc. (QBIO)

Published at

Nov 8, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Nicox, SPARC, Visiox, Glaukos, Ono, Santen, Ocular, Tarsier, Peregrine O

The dynamics of the glaucoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising...

195940.KQ SPARC.NS SKYE QBIO OCUL GKOS

Read more →
Published at

Aug 30, 2023 3:00 AM

by prnewswire.com

neutral

neutral

Autism Spectrum Disorder Therapeutics Market to Grow by USD 772.65 million from 2022 to 2027 | Increasing prevalence of ASD boosts the market growth - Technavio

/PRNewswire/ -- The autism spectrum disorder therapeutics market is set to grow by USD 772.65 million from 2022 to 2027, progressing at a CAGR of 7.2% during...

ZYNE TVTX SPPI QBIO OTSKY OTSKF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JAZZN.MX JAZZ 4578.T 0M40.L 0K9E.L

Read more →
Published at

Aug 14, 2023 2:29 PM

by globenewswire.com

mixed

mixed

Explore Pain Management Therapeutics Market: Valued at $73.6 Billion in 2021, Projected CAGR of 2.9% till 2031 (TMR Report)

Significant usage of pain management drugs, especially prescriptive medications such as non-steroidal anti-inflammatory drugs (NSAIDs), is anticipated to...

ZEG.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ GSK.L GSK GS7.DE GLAXF ENDP DJNJ3.BA DJNJ2.BA AZNN.MX AZNCF AZN.L AZN 6MK.DE 0Y5F.L 0K9E.L 0A4J.L VENUSREM.NS VENUSREM.BO QBIO

Read more →
Published at

Jun 23, 2023 2:01 PM

by marketscreener.com

positive

positive

Q BioMed Inc. Provides Update to Shareholders

NEW YORK, June 23, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders. ...

SCCFF QBIO

Read more →
Published at

Jun 23, 2023 2:00 PM

by prnewswire.com

positive

positive

Q BioMed Inc. Provides Update to Shareholders

/PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical...

SCCFF QBIO

Read more →
Published at

Apr 14, 2023 2:01 PM

by marketscreener.com

positive

positive

Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe

Company's Liver Cancer Drug Candidate IP Portfolio strengthened Company provides operational update on strategic opportunities NEW YORK, April 14, 2023 /PRNewswire/ -- Q BioMed Inc. a biotech... | April 14, 2023

QBIO

Read more →
Published at

Apr 12, 2023 5:30 AM

by prnewswire.com

mixed

mixed

Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio

/PRNewswire/ -- The liver cancer drugs market size is forecast to increase by USD 5.29 billion from 2021 to 2026, at a CAGR of 14.67%, according to the recent...

GIS.DE GILDD.BA GILD.MX GILD EXEL EX9.DE ESALY ESALF DUL.DE ALNY A1LN34.SA 4523.T 0IJO.L 0HD2.L ZEG.DE QBIO PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE OPHLY OPHLF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA AZNN.MX AZNCF AZN.L AZN 4528.T 0K9E.L 0A4J.L

Read more →
Published at

Feb 9, 2023 2:45 AM

by prnewswire.com

mixed

mixed

Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio

/PRNewswire/ -- The global liver cancer drugs market size is estimated to increase by USD 5.29 billion from 2021 to 2026. The market's growth momentum will...

QBIO PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE OPHLY OPHLF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA 4528.T 0K9E.L GIS.DE GILDD.BA GILD.MX GILD EXEL EX9.DE ESALY ESALF DUL.DE ALNY A1LN34.SA 4523.T 0IJO.L 0HD2.L ZEG.DE AZNN.MX AZNCF AZN.L AZN 0A4J.L

Read more →
Published at

Nov 14, 2022 4:35 PM

by prnewswire.com

positive

positive

Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.

/PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce that it has converted...

QBIO

Read more →
Published at

Oct 19, 2022 8:00 PM

by prnewswire.com

mixed

mixed

Pain Management Therapeutics Market | North America is Expected to Hold Largest Share of the Industry to 2031 - TMR Study

/PRNewswire/ -- An evaluation of recent pain management therapeutics market trends highlight that companies are leaning toward bolstering R&D spending toward...

QBIO ZEG.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ ENDP DJNJ3.BA DJNJ2.BA AZNN.MX AZNCF AZN.L AZN 6MK.DE 0Y5F.L 0K9E.L 0A4J.L

Read more →
Published at

Mar 2, 2021 8:54 PM

by benzinga.com

mixed

mixed

Proactive news headlines including Energy Fuels, Tartisan Nickel Corp, Medexus Pharmaceuticals and Falcon Gold

New York, March 02, 2021 (GLOBE NEWSWIRE) -- - Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) signs deal with Neo Performance Materials to launch rare ...

WNT1.F WLI.F VRRCF VRR.V VO51.F VEGA.CN UUUU TTSRF TN.CN SWISF SWIS.CN PSYCF PSYC.CN OWRDF OWLI.CN OQMGF OILS.CN OILFF OIIIF OIII.V NWGIW NUMI.V NTAR.NE NTAR.CN NEXCF N29.F N29.DU N29.BE LR23.MU LR23.F LR23.BE LKYSF L0MA.F KULR GDT.F GBLEF FGLDF FG.V ELYS.NE ELYS EFR.TO DCNPF CRTPF CRDL.TO CODX CLSK C97.MU C97.F BLGO BIOC B003.F B003.BE 8TA.MU 8TA.F 5VR.F 5U9.MU 5U9.F 5U9.BE 3UW.F 3UW.BE 3FA.F VRNDF V5D1.F TECX.CN QBIO P731.F MLSS MEDXF MDP.V HLYK DN.TO AUSAF AUSA.CN

Read more →
Published at

Feb 1, 2021 4:43 PM

by benzinga.com

positive

positive

Proactive news headlines including Algernon Pharmaceuticals, Benchmark Metals, Imagine AR Inc and Q BioMed Inc

New York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW) poised to investigate psychedelic compound DMT as ...

WMD.V WDDMF QBIO EPWCF DRD.JO DRD CYDY CBDT.CN BYRN.CN BYRN BNCHF BNCH.V AUSAF AUSA.CN AGW.F AGNPF AGN.CN 8EC.F 8EC.BE 87CA.MU 87CA.F 4WE.MU 4WE.F 4WE.BE

Read more →